USPTO serial 87565745
DEEP
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- RADEMACHER, APRIL LUEDERS
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DEEP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Fang Xie
Fang Xie GREENBERG TRAURIG, LLP77 W. Wacker DriveSuite 3100Chicago, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell therapy; pharmaceuticals and medical preparations for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; pharmaceuticals and medical preparations of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T cells | ACTIVE | — |
| 040 | Manufacturing services for others in the fields of pharmaceuticals and medicine, namely, manufacturing of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T cells | ACTIVE | — |
| 042 | Pharmaceutical research and development in the fields of immunotherapy, cell therapy, immune cell therapy, and T-cell therapy; research and development of pharmaceuticals for the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; research and development of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, and cell therapeutics; scientific and medical research in the fields of immunology, oncology, biology, biochemistry, and chemistry | ACTIVE | — |
| 044 | Medical services in the fields of immunotherapy, cell therapy, immune cell therapy, and T-cell therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Torque Therapeutics, Inc.
- Other trademarks owned by Torque Therapeutics, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DEEP
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 5, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 5, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 15, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 14, 2020 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 14, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 27, 2020 | EXT5 | SOU EXTENSION 5 FILED | — |
| Aug 27, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 29, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 20, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 20, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 20, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 20, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 28, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 26, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 26, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 26, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 22, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 20, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 20, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 20, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 11, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 25, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 25, 2019 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 15, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 13, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 13, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 13, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 27, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 8, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 2, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 2, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 13, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 27, 2017 | ALIE | ASSIGNED TO LIE | — |
| Nov 15, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 14, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 14, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 14, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 14, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 14, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 15, 2017 | NWAP | NEW APPLICATION ENTERED | — |